NEWS DETAIL
Home » News » News » New Options for STI Screening: Innovative Lyphilized PCR Kits From Bioteke

New Options for STI Screening: Innovative Lyphilized PCR Kits From Bioteke

Views: 3659     Author: BioTeke Corporation     Publish Time: 2025-01-23      Origin: Bioteke

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button
New Options for STI Screening: Innovative Lyphilized PCR Kits From Bioteke

PREFACE
With the increasing incidence of sexually transmitted infections (STIs), rapid and accurate screening technologies have become particularly important in disease prevention and control and individual diagnosis and treatment. Bioteke's STI screening fluorescent PCR test kit provides reliable solutions for clinical, public health and medical laboratories with its excellent performance.
OVERVIEW

Current status and challenges of sexually transmitted infections:

1. STIs are a major issue in the global public health field. The main pathogens include Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Ureaplasma urealyticum (UU), Treponema pallidum (TP), etc. These pathogens may cause a variety of complications, such as infertility, ectopic pregnancy and chronic pelvic inflammatory disease.

2. Traditional detection methods (such as microscopy and culture) are time-consuming and have limited sensitivity, which makes it difficult to meet the needs of rapid diagnosis and early intervention. At this time, fluorescent PCR technology, as an advanced molecular diagnostic tool, provides a more efficient solution.

PRODUCT FEATURES

Bioteke's STI screening kit uses molecular diagnostic technology to accurately detect nucleic acids of multiple pathogens and has the following significant features:


1. Detection limitation: 1000 copies/mL.


2. Precision: The coefficient of variation (CV, %) of Ct value of within-batch/between-batch precision is ≤ 5%.


3. Accuracy: The conformity rate of negative/positive reference: 100%.


4. Strong stability: Freeze-dried system, Taq enzyme, UDG enzyme, reaction buffer, specific primers and probes required for amplification are all lyophilized in PCR tubes. Detection can be performed directly after adding dissolving solution and extracted nucleic acid.

APPLICABILITY

a. Hospitals and clinics

Gynecology, urology and dermatology and venereal disease departments are used for diagnosis and treatment monitoring of suspected patients.

Pre-pregnancy examination to avoid mother-to-child transmission of pathogens.


b. Public health and disease control

It is used for screening of high-risk populations and epidemiological surveys to support STD prevention and control projects.

Provide accurate data and provide a scientific basis for health policy formulation.


c. Testing centers and laboratories

Batch testing services, such as premarital physical examinations, corporate health screening, etc.


d. Scientific research, analyzing the epidemic trends of sexually transmitted infections.


e. Individual health management

Provide convenient sexual health testing, privacy protection and timely diagnosis services for users.

SIGNIFICANCE

Lyphilized PCR system not only improves the efficiency and accuracy of STI testing, but also reduces the cost of diagnosis, providing more possibilities for early diagnosis and timely intervention of diseases. 

In the future, this technology has broad application prospects in personalized medicine and large-scale screening.

PRODUCT DETAILS

Name: Sexually Transmitted Infection(STI) Screening Kit

Model: PR2026-ST01

Package Specification: 24 samples/kit

Shelf Life: 12 months.

Storage: -20±5℃;Transported at Room Temperature within 30 days available.

Applicable Platform: Real-time PCR instrument with FAM/VIC/ROX/CY5 fluorescence channels(ABI7500,Bio-rad CFX96,QuantStudio,SLAN-96S,BTK-96).


Bioteke's sexually transmitted infection screening kit is an important tool in clinical diagnosis and public health. 

Its diverse application scenarios and reliable detection performance provide new possibilities for the prevention and control of sexually transmitted infections. Accurate detection is the first step in disease control. 

Bioteke will continue to promote the development of health with technological innovation.


If you are interested in our products or want to know more, please contact the Bioteke team.


Web: www.bioteke.cn

Phone: +86 18115363743

E-mail: zr@bioteke.cn

Address: No. 9 Huiming Rd, Huishan District, Wuxi, 214174, China.


QUICK LINKS
PRODUCT CENTER
CONTACT US
Placeholder Image

   Telephone/Whatsapp: +86 18115363743

Placeholder Image

  Email : zr@bioteke.cn

Copyright BioTeke Corporation(wuxi) Co.,Ltd  |   苏ICP备18042459号-1